enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Donanemab - Wikipedia

   en.wikipedia.org/wiki/Donanemab

   Donanemab was approved for medical use in the United States in July 2024. [2] [5] Treatment is intended for people with mild cognitive impairment or mild dementia stage of disease, which is the same population the treatment was studied in the clinical trials. [6]

3. Donanemab – what we know about the latest Alzheimer’s drug

   www.aol.com/donanemab-know-latest-alzheimer-drug...

   Our committee is unable to recommend lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease. ... The FDA has granted approval of Kisunla (donanemab) for ...

4. Eli Lilly Alzheimer's drug approved by US FDA - AOL

   www.aol.com/news/us-fda-approves-lillys...

   The approval for donanemab, to be sold under the brand name Kisunla, followed the recommendations of the agency's outside experts, who unanimously backed its use in patients with early Alzheimer's ...

5. Eli Lilly's Alzheimer's drug approved in Japan - AOL

   www.aol.com/news/eli-lillys-alzheimers-drug...

   The Alzheimer's Association estimates that more than 4.6 million people are living with dementia in Japan and it is expected to rise significantly as the country's population ages. Eli Lilly's ...

6. FDA approves donanemab, Eli Lilly’s treatment for early ...

   www.aol.com/fda-approves-donanemab-eli-lilly...

   The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.

7. FDA approves Alzheimer’s treatment that has been shown to ...

   www.aol.com/news/fda-approves-alzheimer...

   The FDA approved a new Alzheimer’s drug that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities. ... The drug donanemab, which will be sold under the ...